RedHill Biopharma (RDHL) EBIT Margin (2012 - 2023)
RedHill Biopharma's EBIT Margin came in at -2776.92% for the year ended Dec 31, 2025, down 2696.42 percentage points from -80.50% a year earlier.
Powered by 
Analysis
RedHill Biopharma (RDHL) EBIT Margin (2012 - 2023) Analysis & Trends
Going back to the year ended Dec 31, 2011, RedHill Biopharma's EBIT Margin data covers 15 years.
- EBIT Margin carries a five-year change of -2875.87 percentage points (years ended Dec 2020 to Dec 2025).
- The figure for the year ended Dec 31, 2025 represents the lowest annual EBIT Margin in data going back to the year ended Dec 31, 2011.
- Per Business Quant, earlier years put EBIT Margin at -80.50% in the year ended Dec 31, 2024 (+65.71 pp), -146.22% in the year ended Dec 31, 2023 (-76.89 pp), -69.33% in the year ended Dec 31, 2022 (+25.28 pp) and -94.61% in the year ended Dec 31, 2021 (-193.56 pp).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 28.21% |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 37.86% |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | -3.52% |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 32.97% |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 20.57% |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 34.95% |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -133.21% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 28.37% |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 37.40% |
| 10 | RedHill Biopharma | 7.53 Mn | 7.53 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2023 | 2,992.87% |
| Mar 31, 2023 | -808.00% |
| Dec 31, 2022 | -591.81% |
| Sep 30, 2022 | 40.50% |
| Jun 30, 2022 | 49.92% |
| Mar 31, 2022 | 126.90% |
| Dec 31, 2021 | -641.43% |
| Sep 30, 2021 | 80.51% |
| Jun 30, 2021 | 115.74% |
| Mar 31, 2021 | 88.22% |
| Dec 31, 2020 | 91.83% |
| Sep 30, 2020 | 69.04% |
| Jun 30, 2020 | 59.81% |
| Mar 31, 2020 | 1,611.36% |
| Dec 31, 2019 | 739.87% |
| Sep 30, 2019 | 702.64% |
| Jun 30, 2019 | 792.07% |
| Mar 31, 2019 | 530.40% |
| Dec 31, 2018 | 739.00% |
| Sep 30, 2018 | 441.34% |
API Access
RedHill Biopharma EBIT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebit-margin&ticker=RDHL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebit-margin", "ticker": "RDHL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebit-margin&ticker=RDHL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();